[go: up one dir, main page]

WO2003015667A8 - Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie - Google Patents

Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie

Info

Publication number
WO2003015667A8
WO2003015667A8 PCT/US2002/024646 US0224646W WO03015667A8 WO 2003015667 A8 WO2003015667 A8 WO 2003015667A8 US 0224646 W US0224646 W US 0224646W WO 03015667 A8 WO03015667 A8 WO 03015667A8
Authority
WO
WIPO (PCT)
Prior art keywords
implant
presbyopia
treatment
intra
glaucoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/024646
Other languages
English (en)
Other versions
WO2003015667A1 (fr
Inventor
David Castillejos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to MXPA04001076A priority Critical patent/MXPA04001076A/es
Priority to CA002455120A priority patent/CA2455120A1/fr
Priority to JP2003520429A priority patent/JP4346438B2/ja
Priority to IL16003702A priority patent/IL160037A0/xx
Priority to EP02768411A priority patent/EP1418864A4/fr
Priority to KR10-2004-7001249A priority patent/KR20040024873A/ko
Priority to BR0215382-3A priority patent/BR0215382A/pt
Publication of WO2003015667A1 publication Critical patent/WO2003015667A1/fr
Anticipated expiration legal-status Critical
Publication of WO2003015667A8 publication Critical patent/WO2003015667A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un implant intra-scléral (10) et un procédé d'implantation utilisé dans le traitement de la pression intraoculaire et de la presbyopie. Cet implant comprend une partie corps (46) pourvue de parties saillantes (48) qui permettent de fixer le dispositif dans une cavité (19) formée dans la paroi sclérale (16) de l'oeil (12). Une fonction d'administration de médicament est éventuellement prévue pour permettre la diffusion à long terme de médicaments dans les tissus qui entourent l'implant.
PCT/US2002/024646 2001-08-03 2002-08-02 Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie Ceased WO2003015667A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MXPA04001076A MXPA04001076A (es) 2001-08-03 2002-08-02 Metodo e implante intraescleral para tratamiento de glaucoma y presbicia.
CA002455120A CA2455120A1 (fr) 2001-08-03 2002-08-02 Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie
JP2003520429A JP4346438B2 (ja) 2001-08-03 2002-08-02 緑内障および老眼の治療のための方法および強膜内インプラント
IL16003702A IL160037A0 (en) 2001-08-03 2002-08-02 Method and intra sclera implant for treatment of glaucoma and presbyopia
EP02768411A EP1418864A4 (fr) 2001-08-03 2002-08-02 Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie
KR10-2004-7001249A KR20040024873A (ko) 2001-08-03 2002-08-02 녹내장과 노안 치료를 위한 공막내 이식장치와 그 방법
BR0215382-3A BR0215382A (pt) 2001-08-03 2002-08-02 Método e implante intra-esclerótico para o tratamento de glaucoma e presbiopia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31002701P 2001-08-03 2001-08-03
US60/310,027 2001-08-03

Publications (2)

Publication Number Publication Date
WO2003015667A1 WO2003015667A1 (fr) 2003-02-27
WO2003015667A8 true WO2003015667A8 (fr) 2004-12-16

Family

ID=33510228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/024646 Ceased WO2003015667A1 (fr) 2001-08-03 2002-08-02 Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie

Country Status (6)

Country Link
EP (1) EP1418864A4 (fr)
JP (1) JP4346438B2 (fr)
KR (1) KR20040024873A (fr)
CA (1) CA2455120A1 (fr)
IL (1) IL160037A0 (fr)
WO (1) WO2003015667A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291125B2 (en) 2003-11-14 2007-11-06 Transcend Medical, Inc. Ocular pressure regulation
US9585789B2 (en) 2007-07-17 2017-03-07 Novartis Ag Ocular implant with hydrogel expansion capabilities

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040225250A1 (en) 2003-05-05 2004-11-11 Michael Yablonski Internal shunt and method for treating glaucoma
US20090306687A1 (en) * 2005-10-31 2009-12-10 Life Spring Biotech Co., Ltd. Scleral buckling band and method for making the same
ES2653845T3 (es) 2006-01-17 2018-02-09 Novartis Ag Dispositivo de tratamiento de administración de fármaco
ES2551782T3 (es) 2006-01-17 2015-11-23 Transcend Medical, Inc. Dispositivo para el tratamiento de glaucoma
NZ571758A (en) * 2006-03-31 2012-06-29 Quadra Logic Tech Inc A drug insert surrounded by a sheath to expose a polymer containing a drug to surrounding tissues or an eye
ES2418842T3 (es) * 2006-07-11 2013-08-16 Refocus Group, Inc. Prótesis escleral para tratar presbicia y otros trastornos oculares y dispositivos de inserción relacionados
KR101501631B1 (ko) * 2007-08-02 2015-03-11 리포쿠스 그룹 인코포레이티드 노안 및 기타 안과 질환을 치료하기 위한 크로스바를 갖는 공막 보철물
DE102008021842A1 (de) 2008-04-30 2009-11-05 Tesa Se Polyolefinfolie und Verwendung derselben
EP2334268B1 (fr) 2008-06-25 2017-08-02 Novartis Ag Implant oculaire à capacité de changement de forme
GB2464981A (en) * 2008-11-01 2010-05-05 Univ Dundee Pressure sensor for measuring intraocular pressure that can be worn on the eye.
WO2010088258A2 (fr) 2009-01-28 2010-08-05 Transcend Medical, Inc. Implant oculaire rigide, procédés d'implantation et système correspondant
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
WO2011155916A1 (fr) * 2010-06-11 2011-12-15 Damiano Richard E Dispositif d'amélioration pour la lecture pour prévenir et traiter la presbytie de l'œil
ES2666857T3 (es) 2011-07-18 2018-05-08 Mor-Research Applications Ltd. Un dispositivo para ajustar la presión intraocular
US10085633B2 (en) 2012-04-19 2018-10-02 Novartis Ag Direct visualization system for glaucoma treatment
US9241832B2 (en) 2012-04-24 2016-01-26 Transcend Medical, Inc. Delivery system for ocular implant
EP2895123B1 (fr) 2012-09-17 2017-06-07 Novartis Ag Dispositifs d'implant oculaire expansible
WO2014078288A1 (fr) 2012-11-14 2014-05-22 Transcend Medical, Inc. Implant oculaire favorisant la circulation
US9987163B2 (en) 2013-04-16 2018-06-05 Novartis Ag Device for dispensing intraocular substances
CN110114038A (zh) * 2016-12-23 2019-08-09 瑞福克斯集团公司 用于治疗远视眼的、具有用于保留在巩膜组织中的一个或多个锯齿状表面或其他表面的巩膜假体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US4946436A (en) * 1989-11-17 1990-08-07 Smith Stewart G Pressure-relieving device and process for implanting
US5178604A (en) 1990-05-31 1993-01-12 Iovision, Inc. Glaucoma implant
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US6102045A (en) 1994-07-22 2000-08-15 Premier Laser Systems, Inc. Method and apparatus for lowering the intraocular pressure of an eye
US5558630A (en) * 1994-12-30 1996-09-24 Fisher; Bret L. Intrascleral implant and method for the regulation of intraocular pressure
US5968058A (en) * 1996-03-27 1999-10-19 Optonol Ltd. Device for and method of implanting an intraocular implant
US6007578A (en) 1997-10-08 1999-12-28 Ras Holding Corp Scleral prosthesis for treatment of presbyopia and other eye disorders
US6079417A (en) 1999-03-23 2000-06-27 Fugo; Richard J. Method of altering the shape of the cornea of the eye

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291125B2 (en) 2003-11-14 2007-11-06 Transcend Medical, Inc. Ocular pressure regulation
US9585789B2 (en) 2007-07-17 2017-03-07 Novartis Ag Ocular implant with hydrogel expansion capabilities

Also Published As

Publication number Publication date
IL160037A0 (en) 2004-06-20
JP2005508213A (ja) 2005-03-31
WO2003015667A1 (fr) 2003-02-27
JP4346438B2 (ja) 2009-10-21
EP1418864A4 (fr) 2009-07-01
CA2455120A1 (fr) 2003-02-27
EP1418864A1 (fr) 2004-05-19
KR20040024873A (ko) 2004-03-22

Similar Documents

Publication Publication Date Title
WO2003015667A8 (fr) Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie
US8267995B2 (en) Method and intra sclera implant for treatment of glaucoma and presbyopia
EP1473003A3 (fr) Dispositif d'administration de médicaments
US6187041B1 (en) Ocular replacement apparatus and method of coupling a prosthesis to an implant
WO2003009774A3 (fr) Dispositif d'administration de medicament ophtalmique
PL369246A1 (en) Ophthalmic drug delivery device
EP2215996A3 (fr) Implant ophtalmique pour traitement du glaucome
EP3141227B1 (fr) Dispositif chirurgical ophtalmique
CA2433849A1 (fr) Dispositif et methode de traitement d'un glaucome
WO2002089699A3 (fr) Dispositif medical et methodes d'utilisation pour le traitement d'un glaucome
TW368411B (en) Biocompatible ocular implants
WO2008039397A2 (fr) Méthode et implant intra-scléral servant à traiter le glaucome et la presbytie
AU2003290089A1 (en) Device for ocular aqueous drainage
WO2002032343A3 (fr) Implant ophtalmique tubulaire a section en forme de c pour la reduction de la tension intraoculaire dans des yeux glaucomateux et procede de mise en oeuvre
WO2003015659A3 (fr) Dispositif de derivation et procede de traitement du glaucome ameliores
IL96242A0 (en) Device and method for relieving intraocular pressure
WO2005020907A3 (fr) Dispositif d'administration oculaire de produit pharmaceutique
AU5857396A (en) Intraocular implant, delivery device, and method of implanta tion
EP1754453A3 (fr) Prothèse sclérale pour traîtement de la presbytie et d'autres troubles oculaires
US6530953B2 (en) Method of magnetically coupling a prosthesis with an ocular implant
BR0215382A (pt) Método e implante intra-esclerótico para o tratamento de glaucoma e presbiopia
WO2003028598A3 (fr) Dispositif d'injection ophthalmique
WO1997015251A1 (fr) Dispositif de compression pneumatique a pression reglable afin d'obtenir et maintenir l'erection du penis sans obstruction de l'uretre
RU2003129193A (ru) Способ хирургического лечения открытоугольной глаукомы
RU2003109628A (ru) Способ хирургического лечения прогрессирующей близорукости

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 160037

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2455120

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020047001249

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/001076

Country of ref document: MX

Ref document number: 2003520429

Country of ref document: JP

Ref document number: 20028152166

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 120/MUMNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2002768411

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002768411

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 09/2003 UNDER (30) REPLACE "60/310,227" BY "60/310,027"

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)